These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1345174)

  • 1. A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers-Danlos syndrome type VI.
    Hyland J; Ala-Kokko L; Royce P; Steinmann B; Kivirikko KI; Myllylä R
    Nat Genet; 1992 Nov; 2(3):228-31. PubMed ID: 1345174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A large duplication in the gene for lysyl hydroxylase accounts for the type VI variant of Ehlers-Danlos syndrome in two siblings.
    Hautala T; Heikkinen J; Kivirikko KI; Myllylä R
    Genomics; 1993 Feb; 15(2):399-404. PubMed ID: 8449506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patient with Ehlers-Danlos syndrome type VI is homozygous for a premature termination codon in exon 14 of the lysyl hydroxylase 1 gene.
    Walker LC; Marini JC; Grange DK; Filie J; Yeowell HN
    Mol Genet Metab; 1999 May; 67(1):74-82. PubMed ID: 10329027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the lysyl hydroxylase 1 gene (PLOD) in six unrelated patients with Ehlers-Danlos syndrome type VI: prenatal exclusion of this disorder in one family.
    Yeowell HN; Walker LC; Farmer B; Heikkinen J; Myllyla R
    Hum Mutat; 2000 Jul; 16(1):90. PubMed ID: 10874315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.
    Yeowell HN; Walker LC
    Mol Genet Metab; 2000; 71(1-2):212-24. PubMed ID: 11001813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers-Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 gene.
    Walker LC; Teebi AS; Marini JC; De Paepe A; Malfait F; Atsawasuwan P; Yamauchi M; Yeowell HN
    Mol Genet Metab; 2004 Dec; 83(4):312-21. PubMed ID: 15589118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common duplication in the lysyl hydroxylase gene of patients with Ehlers Danlos syndrome type VI results in preferential stimulation of lysyl hydroxylase activity and mRNA by hydralazine.
    Yeowell HN; Walker LC; Murad S; Pinnell SR
    Arch Biochem Biophys; 1997 Nov; 347(1):126-31. PubMed ID: 9344473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ehlers-Danlos syndrome type VI results from a nonsense mutation and a splice site-mediated exon-skipping mutation in the lysyl hydroxylase gene.
    Yeowell HN; Walker LC
    Proc Assoc Am Physicians; 1997 Jul; 109(4):383-96. PubMed ID: 9220536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and expression of the human lysyl hydroxylase gene (PLOD): introns 9 and 16 contain Alu sequences at the sites of recombination in Ehlers-Danlos syndrome type VI patients.
    Heikkinen J; Hautala T; Kivirikko KI; Myllylä R
    Genomics; 1994 Dec; 24(3):464-71. PubMed ID: 7713497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the PLOD1 gene: an efficient multistep approach to the molecular diagnosis of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA).
    Giunta C; Randolph A; Steinmann B
    Mol Genet Metab; 2005; 86(1-2):269-76. PubMed ID: 15979919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI.
    Yeowell HN; Walker LC; Marshall MK; Murad S; Pinnell SR
    Arch Biochem Biophys; 1995 Aug; 321(2):510-6. PubMed ID: 7646078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A splice-site mutation that induces exon skipping and reduction in lysyl hydroxylase mRNA levels but does not create a nonsense codon in Ehlers-Danlos syndrome type VI.
    Pajunen L; Suokas M; Hautala T; Kellokumpu S; Tebbe B; Kivirikko KI; Myllylä R
    DNA Cell Biol; 1998 Feb; 17(2):117-23. PubMed ID: 9502428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ehlers-Danlos syndromes.
    Yeowell HN; Pinnell SR
    Semin Dermatol; 1993 Sep; 12(3):229-40. PubMed ID: 8217561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A null-mutated lysyl hydroxylase gene in a compound heterozygote British patient with Ehlers-Danlos syndrome type VI.
    Heikkinen J; Pousi B; Pope M; Myllylä R
    Hum Mutat; 1999 Oct; 14(4):351. PubMed ID: 10502784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A compound heterozygote patient with Ehlers-Danlos syndrome type VI has a deletion in one allele and a splicing defect in the other allele of the lysyl hydroxylase gene.
    Pousi B; Hautala T; Hyland JC; Schröter J; Eckes B; Kivirikko KI; Myllylä R
    Hum Mutat; 1998; 11(1):55-61. PubMed ID: 9450904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ehlers-Danlos syndrome in two siblings with deficient lysyl hydroxylase activity in cultured skin fibroblasts but only mild hydroxylysine deficit in skin.
    Steinmann B; Gitzelmann R; Vogel A; Grant ME; Harwood R; Sear CH
    Helv Paediatr Acta; 1975 Oct; 30(3):255-74. PubMed ID: 1184396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral gene transfer restores lysyl hydroxylase activity in type VI Ehlers-Danlos syndrome.
    Rauma T; Kumpumäki S; Anderson R; Davidson BL; Ruotsalainen H; Myllylä R; Hautala T
    J Invest Dermatol; 2001 Apr; 116(4):602-5. PubMed ID: 11286629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Ehlers Danlos syndrome type VI.
    Salavoura K; Valari M; Kolialexi A; Mavrou A; Kitsiou S
    Genet Couns; 2006; 17(3):291-4. PubMed ID: 17100196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Ehlers-Danlos syndrome type VIA patient with cystic malformations of the meninges.
    Yeowell HN; Walker LC; Neumann LM
    Eur J Dermatol; 2005; 15(5):353-8. PubMed ID: 16172044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
    Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
    Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.